Trial Profile
A Single Dose Pharmacokinetics Study of NPC-01 (1mg Norethisterone and 0.02mg Ethynyl Estradiol) in Healthy Female Volunteers
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Ethinylestradiol/norethisterone (Primary)
- Indications Dysmenorrhoea; Endometriosis; Pregnancy
- Focus Pharmacokinetics
- Sponsors Nobelpharma
- 08 Jun 2011 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 03 Dec 2010 New trial record